文献速递头颈神经CT

头颈部鳞状细胞癌患者颈部淋巴结转移预测评分系统的构建

A Scoring System for Prediction of Cervical Lymph Node Metastasis in Patients with Head and Neck Squamous Cell Carcinoma.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-05-09

本研究基于191例头颈部鳞状细胞癌患者历史队列的476枚颈部淋巴结,分析术前CT特征(最短轴径、长短轴比、坏死、T分期等),构建9分风险评分系统预测淋巴结转移,风险概率从7.3%至99.8%与评分正相关,内部验证AUC为0.886(95%CI 0.881-0.920)和0.879(95%CI 0.845-0.914),Hosmer-Lemeshow检验P=0.160提示校准良好。

要点

  • 9分评分系统基于最短轴径、长短轴比、坏死和T分期,风险概率7.3%-99.8%与评分正相关。
  • 内部验证AUC为0.886(95%CI 0.881-0.920)和0.879(95%CI 0.845-0.914),校准良好(P=0.160)。
  • 该评分系统有助于日常实践中对颈部淋巴结转移风险进行分层并辅助决策。

核心结论

  • 基于CT特征构建的9分风险评分系统可对头颈部鳞状细胞癌患者的颈部淋巴结转移风险进行分层,可能有助于日常实践中的决策。

研究设计与样本

  • 研究为历史队列研究,纳入191例头颈部鳞状细胞癌患者的476枚颈部淋巴结,分析术前CT图像特征,以病理结果为参考标准,采用多变量逻辑回归构建风险评分系统,并以1000次迭代自举法进行内部验证。

关键影像表现/征象

  • 评分系统纳入最短轴径、长短轴比、坏死和T分期,总分9分,风险概率范围7.3%至99.8%与评分升高正相关。

诊断标准与关键数值

  • 9分风险评分系统内部验证AUC为0.886(95%CI 0.881-0.920)和0.879(95%CI 0.845-0.914),Hosmer-Lemeshow拟合优度检验P=0.160提示校准良好。

临床应用与阅片要点

  • 作者认为该评分系统可辅助日常实践中对头颈部鳞状细胞癌患者颈部淋巴结转移风险的决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: An accurate and comprehensive assessment of lymph node metastasis in patients with head and neck squamous cell cancer is crucial in daily practice. This study constructed a predictive model with a risk scoring system based on CT characteristics of lymph nodes and tumors for patients with head and neck squamous cell carcinoma to stratify the risk of lymph node metastasis.

MATERIALS AND METHODS: Data included 476 cervical lymph nodes from 191 patients with head and neck squamous cell carcinoma from a historical cohort. We analyzed preoperative CT images of lymph nodes, including diameter, ratio of long-to-short axis diameter, necrosis, conglomeration, infiltration to adjacent soft tissue, laterality and T-stage of the primary tumor. The reference standard comprised pathologic results. Multivariable logistic regression analysis was performed to develop the risk scoring system. Internal validation was performed with 1000-iteration bootstrapping.

RESULTS: Shortest axial diameter, ratio of long-to-short axis diameter, necrosis, and T-stage were used to develop a 9-point risk scoring system. The risk of malignancy ranged from 7.3% to 99.8%, which was positively associated with increased scores. Areas under the curve of the risk scoring systems were 0.886 (95% CI, 0.881-0.920) and 0.879 (95% CI, 0.845-0.914) in internal validation. The Hosmer-Lemeshow goodness-of-fit test indicated that the risk scoring system was well-calibrated (P = .160).

CONCLUSIONS: We developed a comprehensive and simple risk scoring system using CT characteristics in patients with head and neck squamous cell carcinoma to stratify the risk of lymph node metastasis. It could facilitate decision-making in daily practice.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Chung MS, Choi YJ, Kim SO, et al. A Scoring System for Prediction of Cervical Lymph Node Metastasis in Patients with Head and Neck Squamous Cell Carcinoma. AJNR Am J Neuroradiol. 2019. PMID: 31072971. doi:10.3174/ajnr.A6066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。